NCT07200050

Brief Summary

This study aims to evaluate the effects of a home-based exercise program on patients with fibromyalgia. Participants will be randomly assigned to either an exercise group or a control group. The study will last 12 weeks, and the outcomes will measure improvements in pain, physical function, and quality of life. Participation involves attending scheduled assessments at the Department of Physical Medicine and Rehabilitation, University Hospital. This study helps understand whether a structured home exercise program can benefit individuals with fibromyalgia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

September 12, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
Last Updated

October 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1 year

First QC Date

September 12, 2025

Last Update Submit

September 27, 2025

Conditions

Keywords

FibromyalgiaExerciseHome-basedPainQuality of life

Outcome Measures

Primary Outcomes (1)

  • Change in pain intensity (Visual Analog Scale, VAS)

    Change in pain intensity from baseline to week 12 measured by the Visual Analog Scale (VAS).The VAS ranges from 0 to 10, where 0 indicates no pain and 10 indicates unbearable pain. Higher scores indicate worse pain.

    12 weeks

Secondary Outcomes (4)

  • Change in quality of life (Fibromyalgia Impact Questionnaire, FIQ)

    12 weeks

  • Change in fatigue severity (Visual Analog Scale, VAS)

    12 weeks

  • Change in depressive symptoms (Beck Depression Inventory, BDI)

    12 weeks

  • Change in exercise perception (Exercise Benefits and Barriers Scale, EBBS)

    12 weeks

Study Arms (2)

Home-based Exercise

OTHER

Participants receive usual care without any additional structured exercise program. Assessments are performed at baseline and after 12 weeks.

Other: Home-based Exercise Program

Control

NO INTERVENTION

Participants receive usual care without any additional structured exercise program. Assessments are performed at baseline and after 12 weeks.

Interventions

Participants follow a 12-week home-based exercise program including aerobic, strengthening, and flexibility exercises. Assessments are done at baseline and after 12 weeks.

Home-based Exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female participants (biological sex: female) with fibromyalgia are eligible to participate.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years
  • Voluntary participation in the study
  • Diagnosis of fibromyalgia according to the 2016 ACR criteria
  • Female gender
  • Pain severity score of ≥4/10 on the Visual Analog Scale (VAS)

You may not qualify if:

  • Pregnancy
  • History of malignancy
  • Pre-existing neurological, endocrine, infectious, or inflammatory rheumatic diseases
  • Severe psychiatric disorders
  • Advanced cardiac, respiratory, or musculoskeletal conditions that would prevent exercise
  • Participation in an exercise or physical therapy program within the last 6 months
  • Any changes to current medical treatment during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kütahya Health Sciences University Hospital

Kütahya, Kütahya, 43290, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FibromyalgiaMotor ActivityPain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesBehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nazlı Karaman, MD

    Kütahya Health Sciences University, Department of Physical Medicine and Rehabilitation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No parties were masked in this study
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned in parallel to either the home-based exercise group or the control group. Both groups were assessed at baseline and after 12 weeks. The study was designed to compare the effects of the exercise program versus usual care on pain, physical function, and quality of life in patients with fibromyalgia
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2025

First Posted

October 3, 2025

Study Start

June 20, 2021

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

October 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to privacy and confidentiality concerns of study participants.

Available IPD Datasets

Individual participant data and supporting information will not be shared. Access

Locations